Analyst consensus rating
Relay Therapeutics Analyst Rating: Strong Buy
Direct answer
Relay Therapeutics's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $27.58.
Forecast evidence checked October 12, 2026.
Get free Relay Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $17.86
- Average price target
- $27.58
- High price target
- $32.00
- Low price target
- $20.00
- Low target gap
- +12%
- Target upside
- +54.4%
- High target gap
- +79.2%
- Target range width
- 67.2%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- October 12, 2026
- Valid through
- October 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Relay Therapeutics?
Relay Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $27.58.
How far are Relay Therapeutics's low and high targets from the recorded price?
The low target implies +12%, while the high target implies +79.2%.
How many analysts are included in Relay Therapeutics's consensus?
The verified consensus includes 12 analysts.
How is Relay Therapeutics's target upside or downside calculated?
The average target of $27.58 is divided by the recorded price of $17.86, then one is subtracted to produce +54.4%. This does not guarantee a future return.
When was Relay Therapeutics's analyst forecast verified?
The data was verified on 2026-10-12. The dataset is valid through 2026-10-19.